Cargando…
Stereotactic body radiation therapy using CyberKnife for T1N0M0 lung cancer patients with severe pulmonary dysfunction
We retrospectively investigated the efficacy and safety of stereotactic body radiotherapy (SBRT) for T1N0M0 lung cancer using CyberKnife (CK) among 13 patients with severe pulmonary dysfunction which was defined as forced expiratory volume in 1 s (FEV(1.0)) of <1 L. The prescribed dose was 54 Gy...
Autores principales: | Abe, Takanori, Ryuno, Yasuhiro, Saito, Satoshi, Aoshika, Tomomi, Igari, Mitsunobu, Hirai, Ryuta, Kumazaki, Yu, Kaira, Kyoichi, Kagamu, Hiroshi, Ishida, Hironori, Noda, Shin-ei, Kato, Shingo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7674703/ https://www.ncbi.nlm.nih.gov/pubmed/32880653 http://dx.doi.org/10.1093/jrr/rraa075 |
Ejemplares similares
-
High-dose stereotactic body radiotherapy using CyberKnife® for stage I peripheral lung cancer: a single-center retrospective study
por: Ryuno, Yasuhiro, et al.
Publicado: (2022) -
Incidence and dose-volume relationship of radiation pneumonitis after concurrent chemoradiotherapy followed by durvalumab for locally advanced non-small cell lung cancer
por: Saito, Satoshi, et al.
Publicado: (2020) -
Feasibility of intensity modulated radiotherapy with involved field radiotherapy for Japanese patients with locally advanced non-small cell lung cancer
por: Abe, Takanori, et al.
Publicado: (2021) -
Incidence and risk factors for pneumonitis among patients with lung cancer who received immune checkpoint inhibitors after palliative thoracic radiotherapy
por: Saito, Satoshi, et al.
Publicado: (2021) -
Effect of durvalumab on local control after concurrent chemoradiotherapy for locally advanced non‐small cell lung cancer in comparison with chemoradiotherapy alone
por: Abe, Takanori, et al.
Publicado: (2020)